Table 2 Correlation of microsatellite instability and clinicopathologic features with survival
5-year survival % (95% confidence intervals) | P-value | |
|---|---|---|
MSI status | ||
MSI-H | 34 (22–52) | 0.3 |
MSS | 41 (23–73) | |
Stage | ||
A, B | 68 (46–100) | 0.005 |
C, D | 28 (17–44) | |
Age (years) | ||
<70 | 33 (20–53) | 0.9 |
≥70 | 42 (26–68) | |
Sex | ||
Female | 36 (20–63) | 0.7 |
Male | 37 (25–56) | |
Site | ||
Right | 33 (20–54) | 0.6 |
Left | 47 (27–80) | |
Vascular invasion | ||
Present | 42 (29–62) | 0.4 |
Absent | 16 (5–52) | |
Tumor lymphocytes | ||
<2 per HPF | 36 (26–52) | 0.3 |
≥2 per HPF | 41 (29–81) | |
Crohn-like reaction | ||
Absent | 33 (21–50) | 0.1 |
Present | 47 (27–79) |
